Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2013 3
2014 1
2015 2
2017 4
2018 5
2019 4
2020 2
2021 5
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for zeidi m[au]
Your search for Zneidi M[au] retrieved no results
Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial.
Werth VP, Hejazi E, Pena SM, Haber J, Zeidi M, Reddy N, Okawa J, Feng R, Bashir MM, Gebre K, Jadoo AS, Concha JSS, Dgetluck N, Constantine S, White B. Werth VP, et al. Among authors: zeidi m. J Invest Dermatol. 2022 Oct;142(10):2651-2659.e1. doi: 10.1016/j.jid.2022.03.029. Epub 2022 Apr 29. J Invest Dermatol. 2022. PMID: 35490744 Free PMC article. Clinical Trial.
Archaeobotanical archiving--response.
Zeidi M, Conard NJ, Riehl S. Zeidi M, et al. Science. 2013 Aug 23;341(6148):840. doi: 10.1126/science.341.6148.840-b. Science. 2013. PMID: 23970679 No abstract available.
Itch in dermatomyositis: the role of increased skin interleukin-31.
Kim HJ, Zeidi M, Bonciani D, Pena SM, Tiao J, Sahu S, Werth VP. Kim HJ, et al. Among authors: zeidi m. Br J Dermatol. 2018 Sep;179(3):669-678. doi: 10.1111/bjd.16498. Epub 2018 Jun 21. Br J Dermatol. 2018. PMID: 29494763 Free PMC article. Clinical Trial.
Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of LenabasumTM.
Maddukuri S, Patel J, Diaz A, Chen KL, Wysocka M, Bax C, Li Y, Ravishankar A, Grinnell M, Zeidi M, Reddy N, Concha JSS, Bashir MM, Okawa J, White B, Werth VP. Maddukuri S, et al. Among authors: zeidi m. Arthritis Res Ther. 2022 Jan 4;24(1):12. doi: 10.1186/s13075-021-02665-x. Arthritis Res Ther. 2022. PMID: 34983619 Free PMC article.
30 results